
Fulcrum Therapeutics Inc. (FULC) Q3 2024 Earnings Call Transcript: A Clever and Personable Look at Fulcrum’s Unconventional Success
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Q3 2024 Earnings Conference Call Company Participants: Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – Senior Vice President, Early Development Patrick Horn – Chief Medical Officer Conference Call Participants: Matthew Biegler – Oppenheimer Dae Gon Ha – Stifel Edward Tenthoff –…